Overview
Salaries
Products
People
Growth
Offices
Financials

Overview

ImageneBio is a clinical-stage biotechnology company developing therapeutics for patients who have immunological, autoimmune and inflammatory diseases. IMG-007 is our next-generation investigational anti-OX40 monoclonal antibody.

People

Sergio Santillana
Executive Officer
Michelle Zhang
Executive Officer
Jotin Marango
Executive Officer
Jeffrey Ecsedy
Executive Officer
Mark Manfredi
Executive Officer, Director
Maria Koehler
Director
Richard Wooster
Director
Iain Dukes
Director
Owen Hughes
Director
Otello Stampacchia
Director
Jean-Francois Formela
Director
David Bonita
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Boston United States
HQ
200-500 est. staff

Financials

Total raised
$42.6M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
Round Announced Amount
Venture - Series Unknown 2023 $42.6M Details